• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/8

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

8 Cards in this Set

  • Front
  • Back
  • 3rd side (hint)
Levodopa
converted to dopamine in the brain and peripheral tissues(undesirable as causes n/v, hypotension), replenishing depleted striatal dopamine
carbidopa/benserazide = dopa decarboxylase inhibitors
entacapone = COMT inhibitor (more levodopa for the brain) and dec. peripheral adverse effects
D: 300-800mg d in 3 or more doses
I: PK
SE: n/v
orthostatic hypotension,
dyskinesia
psych sx (depression, hallucinations, agitation, confusion)
anorexia
insomnia
mydriasis (dilation of pupil)
C: 1, 9, 16
! take this medication at the same time each day and in the same way (e.g. always before food)
! may cause discolouration of urine (red) and faeces (black)
! do not crush, chew or halve CR preps (A)
MONITOR:
LFT (entacapone)
GI bleeding
HR, BP
Dopamine Agonists
I: Parkinson’s disease
Acromegaly (where surgery/radiotherapy ineffective or C.I.)
Hyperprolactinaemia, including prolactinomas

SE: n/v (act on DA receptors in
CTZ)
GI upset
orthostatic hypotension,
dizzy
psych sx (hallucinations, confusion, delusions, psychotic episodes),
dyskinesia
fatigue
impulse control disorders
12, 16, B
! with or soon after food (reduce chance of nausea and stomach upset)
! start at night
start low, go slow
Bromocriptine
PD: 10-40mg d (divd doses)
hyperprolactinaemia: 1.25mg bd, tds
Lactation: 2.5mg BD for 14d
MONITOR:
prolactin levels
visual field (pituitary enlargment)
BP
behaviour
progressive fibrotic disorders
Cabergoline
PD: 3mg d
HP: max 2mg/week
Lactation: 1mg as a single dose first day post partum
MONITOR:
prolactin levels
visual field (pituitary enlargment)
BP
behaviour
progressive fibrotic disorders
Pergolide
PD: 3mg in 3 divid doses (M 5mg d)
MONITOR:
manufacturer recommends regular CV evaluation ECG @ 0, 3-6, then every 6-12months
Amantadine
Increases dopamine release and blocks cholinergic receptors; glutamate antagonist
D: 100mg d (bd < 65yo)
I: Parkinson’s disease
Prevention of influenza type A in non-immunised people (100 mg bd for 10 days)
SE: dry mouth, blurred vision,
constipation, urinary
retention, orthostatic
hypotension, dizziness,
depression, nightmares,
hallucinations
9, 12, 16, B (red. stomach upset)
MONITOR:
Vision
Anticholinergics
blocks muscarinic actions of Ach thus DEC. the relative excess of
cholinergic activity that accompanies dopamine deficiency
in PD
I: PD
Drug-induced EPS (except tardive dyskinesia) [1-4mg od or bd]
SE: rash, dry mouth/eyes, blurred vision, constipation, urinary retention, arrhythmia, dizziness, drowsiness, headache
1, 9, 16
MONITOR:
IOP
Benztropine
D: 6mg d